ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,543Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 47

$476K Total Retail Price of All Prescriptions

Rank: 10 out of 47

399 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Wyoming
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 443 413 86 1 1
LISINOPRIL 419 327 78 2 3
SIMVASTATIN 320 275 61 3 2
FUROSEMIDE 318 281 49 4 5
AMLODIPINE BESYLATE 303 265 54 5 6
METOPROLOL TARTRATE 296 245 61 6 12
ATORVASTATIN CALCIUM 274 251 55 7 8
WARFARIN SODIUM 253 204 32 8 9
OMEPRAZOLE 239 197 40 9 4
POTASSIUM CHLORIDE 220 188 35 10 11
HYDROCHLOROTHIAZIDE 191 177 30 11 15
METFORMIN HCL 182 148 34 12 10
PRAVASTATIN SODIUM 176 122 30 13 18
LOSARTAN POTASSIUM 169 164* 33 14 13
SERTRALINE HCL 137 103 17 15 20
CLOPIDOGREL 128 106 21 16 29
TAMSULOSIN HCL 123 100 20 17 31
HYDROCODONE-ACETAMINOPHEN 117 91 26 S3 18 7
METOPROLOL SUCCINATE 116 111* 31 19 16
CYMBALTA 102 81 13 20 27
ATENOLOL 95 90* 15 21 19
TRIAMTERENE-HCTZ 92 80 20 22 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 70 21 23 36
CRESTOR 88 63 14 24 24
GLIPIZIDE 87 87 14 25 65
ADVAIR DISKUS 82 51 16 26 44
OXYBUTYNIN CHLORIDE 81 <11 <11 27 63
GABAPENTIN 80 65 12 28 14
CLONIDINE HCL 79 <11 <11 29 87
ALPRAZOLAM 77 48 18 B 30 51
TRAZODONE HCL 74 <11 <11 31 48
NEXIUM 68 63* 12 32 32
ZOLPIDEM TARTRATE 68 68 17 32 22
BYSTOLIC 65 <11 <11 34 66
ALLOPURINOL 65 53 14 34 17
ISOSORBIDE MONONITRATE ER 65 60* 11 34 89
CITALOPRAM HBR 65 <11 <11 34 21
PROAIR HFA 63 58* 25 38 62
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 12 39 42
AMITRIPTYLINE HCL 56 23 11 R 40 69
ESCITALOPRAM OXALATE 55 <11 <11 41 43
KLOR-CON 10 54 <11 <11 42 167
ENALAPRIL MALEATE 52 <11 <11 43 61
PHENYTOIN SODIUM EXTENDED 52 <11 <11 43 107
JANUVIA 51 <11 <11 45 52
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.